A systematic review and meta-analysis evaluating the results of more than 4000 patients using JAK3 inhibitors for the treatment of rheumatoid arthritis concluded that the treated group showed significant improvement in signs and symptoms compared to other groups [51]. The gene discussed is JAK3; the disease is rheumatoid arthritis.